$OMDA

Gracey Craig sold $37K of OMDA

Gracey Craig (Chief Accounting Officer) sold 2,083 shares of Omada Health, Inc. (OMDA) at $18.00 on 2026-06-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Gracey Craig
Published Jun 24, 2026, 8:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 24, 2026, 8:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$OMDA
Neutral
high confidence
Mentioned
$OMDA
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

This disclosure updates the insider-trading record but does not indicate a new fundamental catalyst (no guidance, deal, litigation, or regulatory action).

02

Market read

Traders may log the sale for sentiment/positioning, but it is unlikely to drive a standalone repricing.

03

What to watch

The sale size and 10b5-1 structure reduce interpretability; without additional context (e.g., multiple concurrent sales, option exercises, or earnings proximity), signal quality is low.

Relevance 2/10Novelty 3/10Timing: Filed 2026-06-24 after-hours; reflects sale executed 2026-06-22.

Background

SEC Form 4 reports an insider transaction by Omada Health’s Chief Accounting Officer, Gracey Craig, executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$OMDANeutralHigh confidence
Context

Omada Health CFO Gracey Craig sold 2,083 shares in an open-market transaction at $18.00 on 2026-06-22 under a 10b5-1 plan.

Expected impact

Minimal near-term impact; any effect is likely noise unless paired with other disclosures.

Evidence & confidence

The filing is a Form 4 insider transaction with a pre-arranged 10b5-1 plan and a relatively small dollar amount versus typical OMDA trading/market cap.

Market effects

No clear sector read-through; this is company-specific insider liquidity rather than operational/regulatory change.

None.

None.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with private concerns; traders may watch for clustering of sales around specific events.

Key entities

  • Omada Health, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Gracey Craig

    Chief Accounting Officer who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OMDALowAI 8/10

Omada Health reports weight loss study results for GLP-1 program

Omada Health (NASDAQ:OMDA) presented a 12-week study at the World Obesity and Weight Management Congress, showing its GLP-1 Care Track program led to 6.0% average weight loss vs. 3.3% for usual care. The study, published in Diabetes, Obesity and Metabolism, involved 245 adults with obesity. Omada's program also improved body composition, well-being, and reduced depression/anxiety symptoms.

$OMDAHighAI 9/10

Omada Health (OMDA) Q2 2026 Earnings Call Transcript

Omada Health (OMDA) reported Q2 2026 revenue of $88 million, up 43% year over year, with GAAP gross margin of 73% and GAAP net income of $5 million. Adjusted EBITDA was $11 million. The company raised full-year revenue guidance to $334 million to $340 million and adjusted EBITDA to $21 million to $27 million, citing member growth and lower cost to serve.

$OMDAHigh

Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Become Executive Chair and Wei-Li Shao to Become Ch

$RENTMed

Nexus Capital Management LP (Cohen Michael S, Flesh Daniel E.) purchased $2.2M of RENT (indirect holdings)

Nexus Capital Management LP purchased 632,922 indirectly-held shares of Rent the Runway, Inc. (RENT) at $3.55 ($2.25M total) on 2026-10-21. Filed jointly with Gateway Runway, LLC (Director), Gateway Runway Intermediate Holdings, Inc. (Director), NEXUS SPECIAL SITUATIONS III, L.P. (Director), NEXUS SPECIAL SITUATIONS III (CAYMAN), L.P. (Director), Nexus Special Situations GP III, LP (Director), Nexus Partners III, LLC (Director), Cohen Michael S (Director), Flesh Daniel E. (Director) and Giangiacomo Damian (Director).